CD8A and myeloid sarcoma: A reduction of CD8+CD161+ MAIT cells was also reported in MS patients after treatment with dimethyl fumarate, in a study aimed at investigating changes in immune cell subsets of MS patients, that were independent of the drug effects on the absolute lymphocyte count [81].